drugset / Trial / NCT02359110

Administration of Pre-Operative Gabapentin to Patients Undergoing Laparoscopy

NCT02359110 ↗

Phase 4 Completed 112 enrolled Milton S. Hershey Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to prospectively determine the influence of immediate pre-operative gabapentin administration on acute postoperative pain. The investigators hypothesize that immediate post-operative pain will be improved with pre-operative administration of gabapentin.

Timeline

Start
2015-06
Primary completion
2017-01
Completion
2017-01

Outcome

Missed primary endpoint

registry analysis (superiority test); Gabapentin vs Placebo; p = 0.89; Mean Difference (Final Values) 0.1 (95% CI -1.2 to 1.3); Mixed Models Analysis NCT02359110 ↗

registry analysis (superiority test); Gabapentin vs Placebo; p = 0.94; Mean Difference (Final Values) -0.1 (95% CI -1.6 to 1.5); Mixed Models Analysis NCT02359110 ↗

registry analysis (superiority test); Gabapentin vs Placebo; p = 0.64; Mean Difference (Final Values) -0.4 (95% CI -2.2 to 1.3); Mixed Models Analysis NCT02359110 ↗

registry analysis (superiority test); Gabapentin vs Placebo; p = 0.59; Mean Difference (Final Values) 0.6 (95% CI -1.6 to 2.8); Mixed Models Analysis NCT02359110 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Unknown 300 mg —

Indications

No indication recorded.